Target intelligence / Profile preview

Vaccinia virus A27L protein (A27L)

Target
A27L
Molecular classification
Viral envelope protein, Coiled-coil protein
01

Overview

The Vaccinia virus A27L protein is a 110-amino-acid viral envelope protein conserved in the Orthopoxvirus genus, located on the surface of intracellular mature virions. It comprises a heparin-binding domain (residues 21-34), coiled-coil domain (residues 43-84) for oligomerization, and leucine zipper domain for A17 binding. The protein forms trimers as basic units that stack into hexamers via N-terminal and C-terminal interfaces, critical for self-assembly, disulfide-linked complex formation with A26, and biological functions including heparan sulfate binding for cell attachment, A26 packaging, mature virus egress, and modulation of plasma membrane fusion during entry. Mutations disrupting oligomerization impair plaque formation, virus egress, and A26 interaction, leading to increased fusion activity. As a neutralizing antibody target, its structure supports inhibitor development against poxvirus infection.

Other names
A27 proteinA2714-kilodalton fusion protein
02

Biological functions

Binds cell surface heparan sulfateAnchors A26 protein into mature virionsEssential for mature virus egressMediates virus attachment to cell surface glycosaminoglycansRegulates membrane fusion during virus entryInteracts with A17 and A26 proteinsSelf-oligomerizes into trimers/hexamers
03

Disease associations

Infection (poxvirus, orthopoxvirus)

Beyond the preview

Go deeper on Vaccinia virus A27L protein (A27L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaccinia virus A27L protein (A27L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call